The Clinical Implications of RSK1-3 in Human Breast Cancer

Huishan Zhao1, Tracey A Martin2, Eleri L Davies3

  • 1Cardiff-China Medical Research Collaborative, Cardiff University School of Medicine, Heath Park, Cardiff, U.K. Department of Biochemistry and Molecular Biology, Basic Medicine School, Cancer Institute of Capital Medical University, Beijing, P.R. China Capital Medical University-Cardiff University Joint Centre for Biomedical Research; Beijing International Cooperation Base for Science and Technology on China-UK Cancer Research, Capital Medical University, Beijing, P.R. China Beijing Key Laboratory for Cancer Invasion and Metastasis Research, Beijing, P.R. China.

Anticancer Research
|March 16, 2016
PubMed
Abstract

Insights

Ribosomal S6 protein kinase (RSK) family members RSK1 and RSK3 are down-regulated in breast tumors, impacting disease progression. RSK inhibition suppresses breast cancer cell adhesion and invasion, suggesting RSK is crucial for metastasis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • The ribosomal S6 protein kinase (RSK) family, a key effector of ERK/MAPK signaling, influences tumor metastasis through protein phosphorylation.
  • Aberrant RSK expression is observed in malignancies, but its specific role in breast cancer remains unclear.

Purpose of the Study:

  • To investigate the expression of RSK1-3 in human breast cancer specimens.
  • To determine the role of RSK in breast cancer metastasis and cellular processes like adhesion and invasion.

Main Methods:

  • Quantitative real-time PCR (Q-PCR) and immunohistochemistry were used to assess RSK1-3 expression in 112 breast cancer tissues and 33 normal tissues.
  • Breast cancer cell lines (MCF-7 and MDA-231) were treated with RSK inhibitors (SL0101, BRD7389) to evaluate effects on migration, adhesion, and invasion using electric cell impedance sensing (ECIS) and in vitro models.

Main Results:

  • RSK1 and RSK3 expression were significantly lower in tumor tissues compared to normal tissues.
  • RSK2 mRNA expression negatively correlated with tumor grade, TNM stage, and patient survival rate.
  • RSK inhibition by SL0101 reduced adhesion in MCF-7 and MDA-231 cells and suppressed MDA-231 invasion. BRD7389 inhibited invasion in both cell lines.

Conclusions:

  • RSK1 and RSK3 are downregulated in breast tumors and linked to disease progression.
  • RSK signaling plays a critical role in breast cancer progression and metastasis.
  • Targeting RSK may offer a therapeutic strategy for breast cancer treatment.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K